Maternal immunization

Obstetrics and Gynecology Clinics of North America

Volumn 30, Issue 4, 2003, Pages 623-636

  Gall, Stanley A ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BETA LACTAM ANTIBIOTIC; CHICKENPOX ANTIBODY; CHICKENPOX VACCINE; DIPHTHERIA TETANUS TOXOID; ERYTHROMYCIN; HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS ANTIBODY; ORAL POLIOMYELITIS VACCINE; PENICILLIN G; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES IMMUNOGLOBULIN; TETANUS ANTIBODY; UNCLASSIFIED DRUG; YELLOW FEVER VACCINE;

BOTULISM; BREAST FEEDING; CHICKENPOX; CONGENITAL MALFORMATION; DIPHTHERIA; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG SAFETY; EPIDEMIC; FETOTOXICITY; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INTRAUTERINE GROWTH RETARDATION; MATERNAL CARE; MEASLES; MEASLES VACCINATION; MENINGOCOCCEMIA; NEISSERIA MENINGITIDIS; PENICILLIN RESISTANCE; POLIOMYELITIS; PREGNANCY; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SPONTANEOUS ABORTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TERATOGENICITY; TETANUS; TREATMENT INDICATION; VARICELLA ZOSTER VIRUS; VIRUS TRANSMISSION; YELLOW FEVER;

EID: 0346362344     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(03)00085-8     Document Type: Review

References (38)

1. Centers for Disease Control and Prevention. Summary of notifiable disease in the United States. MMWR Morb Mortal Wkly Rep 1998;46:1-87.
2. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48:RR-12.
3. Tassopoulos NC, Papevangelou GJ, Ticehurst JR, Purcell RH. Fecal excretion of Greek strains of hepatitis A virus in patients with hepatitis A and in experimentally infected chimpanzees. J Infect Dis 1986;154:231-9.
4. Lemon SM. The natural history of hepatitis A: the potential for transmission by transfusion of blood or blood products. Vox Sang 1994;67(Suppl 4):19-23.
5. Burk RD, Hwang LY, Ho GYF, et al. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994;170:14-8.
6. Deseda CC, Sweeney PA, Woodruff BA, et al. Prevalence of hepatitis B, hepatitis C and human immunodeficiency virus infection among women attending prenatal clinic in San Juan from 1989-1990. Obstet Gynecol 1995;85:75-8.
7. Hieber JP, Dalton D, Shorey J, et al. Hepatitis and pregnancy. J Pediatr 1977;91:545-9.
8. Glezen WP. Serious morbidity and mortality associated with influenza epidemic [review]. Epidemiol Rev 1982;4:25-44.
9. Harris JW. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAMA 1919;72:978-80.
10. Freeman DW, Bamo A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959;78:1172-5.
11. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiorespiratory hospitalizations in pregnant women. Am J Epidemiol 1998;148:1094-102.
12. Neuzil KM, Nellen BG, Wright PF, Mitchell EF, Griffin MR. Effect of influenza on hospitalization outpatient visits and courses of antibiotics in children. N Engl J Med 2000;342:225-31.
13. Schoenbaum SC, Weinstein L. Respiratory infection in pregnancy. Clin Obstet Gynecol 1979;22: 293-300.
14. Kort BA, Cefalo RC, Baker VV. Fatal influenza A pneumonia in pregnancy. Am J Perinatol 1986; 3:179-82.
15. Heinonen OP, Shapero S, Monson RR, Hartz SC, Rosenberg L, Slone D. Immunization during pregnancy against polio myelitis and influenza in relation to childhood malignancy. Int J Epidemiol 1973;2:229-35.
16. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-8):1-24.
17. Kuikka A, Syrjanen J, Renkonen OV, Valtonen V. Pneumococcal bacteremia during a recent decade. J Infect 1992;24:157-68.
18. Afessa B, Freaver WL, Frederick WR. Pneumococcal bacteremia in adults: a 14 year experience in an inner city university hospital. Clin Infect Dis 1995;21:345-51.
19. Benedetti TJ, Valle R, Ledger WJ. Antepartum pneumonia in pregnancy. Am J Obstet Gynecol 1982;144:413.
20. Siberkoff MS. Drug resistant pneumococcal infections in the United States: a problem for clinicians, laboratories and public health. JAMA 1994;271:1875-6.
21. Friedland IR, McCracken GH. Management of infections caused by antibiotic resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
22. Doem GV, Heclmarra KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 2001;45:1721-9.
23. Butler JC, Hofmann J, Citron MS. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system. J Infect Dis 1996;174:986-93.
24. Nuorti JP, Butler JC, Crutcher JM. An outbreak of multidrug resistant pneumococcal pneumonia among unvaccinated nursing home residents. N Engl J Med 1998;338:1861-8.
25. Austrian R. Pneumococcal polysaccharide vaccines. Rev Infect Dis 1989;11(Suppl):S598-602.
26. Nuorti JP, Butler JC, Farley CC. Cigarette smoking and invasive pneumococcal disease. N Engl J Med 2000;342:681-9.
27. O'Dempsey TJD, McArdle T, Ceesay SJ, Banya WA, Demba E, Secka O, et al. Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy. Vaccine 1996;14:963-70.
28. Centers for Disease Control and Prevention. Diphtheria, tetanus, pertussis: recommendation for vaccine use and other preventative measures. Recommendation of the Advisory Committee on Immunization Practice (ACIP). MMWR Morb Mortal Wkly Rep 1991;40(RR-10):1-28.
29. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: updated recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR Morb Mortal Wkly Rep 2000;49(RR-5):1-22.
30. Centers for Disease Control and Prevention. Prevention of varicella: update recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR Morb Mortal Wkly Rep 1999;48(RR-6):1-5.
31. Shields KE, Galil K, Seward J, Shanac RG, Cordero JF, Slater E. Varicella exposure during pregnancy: data from first 5 years of the pregnancy registry. Obstet Gynecol 2001;98:14-9.
32. Jackson LA, Wenger JD. Laboratory based surveillance for meningococcal disease in selected areas, United States 1989-1991. MMWR Morb Mortal Wkly Rep 1993;42:21.
33. McCormick JB, Gusmao HH, Vakamura S. Antibody response to serogroup A and C meningococcal vaccines in infants born to mothers vaccinated during pregnancy. J Clin Invest 1980;65: 1141-4.
34. Nasidi A, Monath TP, Vandenberg J. Yellow fever vaccination and pregnancy: a four year prospective study. Trans R Soc Trop Med Hygiene 1993;87:337-9.
35. Nishioka S, Nunes-Araujo FR, Pires WP, Silva FA, Costa HL. Yellow fever vaccination during pregnancy and spontaneous abortion: a case controlled study. Trap Med Int Health 1993;3:29-33.
36. Tsai TF, Pau R, Lynber MC, Letson GW. Congenital yellow fever virus infection after immunization in pregnancy. J Infect Dis 1993;168:1520-3.
37. Centers for Disease Control and Prevention. Yellow fever vaccine: recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2002;51(RR-17):1-11.
38. Lee S, Evert D, Frederick P. Resurgence of congenital rubella syndrome in the 1990s. JAMA 1992;267:2616-20.